Become a Patron!

This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy?

Status
Not open for further replies.

VUBot

Staff member
Diamond Contributor
ECF Refugee
Vape Media
In This Article: What's going on with CRISPR Therapeutics (NASDAQ: CRSP)? The company's shares have been southbound for the better part of three years. And despite major regulatory wins since late 2023, the biotech hasn't recovered: The stock is down 23% year to date. Can CRISPR Therapeutics…

Continue reading...
 
Status
Not open for further replies.

VU Sponsors

Top